nach oben

Erschienen in:

01.10.2009 | Original Article

Perceived Susceptibility to Chronic Kidney Disease among High-risk Patients Seen in Primary Care Practices

verfasst von: L. Ebony Boulware, MD, MPH, Kathryn A. Carson, ScM, Misty U. Troll, MPH, Neil R. Powe, MD, MPH, MBA, Lisa A. Cooper, MD, MPH

Erschienen in: Journal of General Internal Medicine | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

BACKGROUND

Patients’ views of their risk for the development or progression of chronic kidney disease (CKD) are poorly characterized.

OBJECTIVE

To assess perceived risk and concern regarding CKD development or progression among high-risk patients seen in primary care, identify predictors of perceptions, and correlate perceptions with adherence to high blood pressure management.

DESIGN AND PARTICIPANTS

Cross-sectional study of 195 patients enrolled in a randomized controlled trial on hypertension management in 40 Maryland primary care practices.

MEASUREMENTS

We assessed independent predictors (sociodemographics, health literacy, clinical presence of CKD, co-morbid conditions, and health behaviors) of perceived susceptibility (assessed via questionnaire) and adherence (assessed via Hill-Bone blood pressure adherence scale) in multivariable analyses.

MAIN RESULTS

In this hypertensive majority African American (63%) population, many participants had uncontrolled blood pressure (44%) or diabetes (42%). Few (20%) felt “very likely” to develop CKD and one third (33%) were “very concerned” about developing CKD. Participants who were female and had low health literacy had lower perceived susceptibility to CKD compared to males and those with higher health literacy. Race and diabetes were also associated with perceived susceptibility. Greater perceived susceptibility was associated with poorer blood pressure management adherence scores.

CONCLUSIONS

Many high-risk patients have low perceived susceptibility to CKD. Poor blood pressure therapy adherence scores among those with greatest perceived susceptibility suggest fatalistic attitudes about CKD. If our findings are confirmed in larger studies, interventions targeting patient perceptions of CKD risk and other attitudes associated with these perceptions could impact adherence to therapies and health outcomes.

Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.CrossRefPubMed

Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352(20):2049–60.CrossRefPubMed

Sarnak MJ, Katz R, Stehman-Breen CO, et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med. 2005;142(7):497–505.PubMed

Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14(11):2934–41.CrossRefPubMed

Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER 3rd. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med. 2005;165(19):2299–304.CrossRefPubMed

Hostetter TH, Lising M. National kidney disease education program. J Am Soc Nephrol. 2003;14(7 Suppl 2):S114–116.CrossRefPubMed

NKDEP Urges Primary Care for People with CKD. NIH Publication No. 08-4531 [http://kidney.niddk.nih.gov/about/Research_Updates/KidneyDiseaseWin08/6.htm. Accessed August, 2009]

Peralta CA, Hicks LS, Chertow GM, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45(6):1119–24.CrossRefPubMed

Pathman DE, Konrad TR, Freed GL, Freeman VA, Koch GG. The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations. Med Care. 1996;34(9):873–89.CrossRefPubMed

10.

Kirkman MS, Williams SR, Caffrey HH, Marrero DG. Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care. 2002;25(11):1946–51.CrossRefPubMed

11.

Cooper LA, Roter DL, Bone LR, et al. A randomized controlled trial of interventions to enhance patient-physician partnership, patient adherence and high blood pressure control among ethnic minorities and poor persons: study protocol NCT00123045. Implement Sci. 2009;4:7.CrossRefPubMed

12.

Davis TC, Crouch MA, Long SW, et al. Rapid assessment of literacy levels of adult primary care patients. Fam Med. 1991;23(6):433–5.PubMed

13.

Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15(3):90–6.CrossRefPubMed

14.

Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.CrossRefPubMed

15.

Expert Panel on the Identification E, Treatment of Overweight in A. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr. 1998;68(4):899–917.

16.

Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1.CrossRefPubMed

17.

Huber PJ. The Behavior of Maximum Likelihood Estimates under Nonstandard Conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Berkeley, CA: University of California Press;1967:221–3.

18.

White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 48:817–30.

19.

Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645–6.CrossRefPubMed

20.

Rogers WH. Regressions standard errors in clustered samples. Stata Tech Bull. 1993;13:19–23.

21.

Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16(1):180–8.CrossRefPubMed

22.

Waterman AD, Browne T, Waterman BM, Gladstone EH, Hostetter T. Attitudes and behaviors of African Americans regarding early detection of kidney disease. Am J Kidney Dis. 2008;51(4):554–62.CrossRefPubMed

23.

National Kidney F. Annual data report: Kidney Early Evaluation Program. American Jounal of Kidney Diseases. 2003;42(5):Supplement 4.

24.

Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T. CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis. 2006;47(1):72–7.CrossRefPubMed

25.

Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48(2):192–204.CrossRefPubMed

26.

Davis RE, Dolan G, Thomas S, et al. Exploring doctor and patient views about risk communication and shared decision-making in the consultation. Health Expect. 2003;6(3):198–207.CrossRefPubMed

27.

Royak-Schaler R, Lemkau JP, Ahmed SM. Discussing breast cancer risk in primary care. J Am Med Womens Assoc. 2002;57(2):115–6.PubMed

28.

Buchanan AH, Skinner CS, Rawl SM, et al. Patients’ interest in discussing cancer risk and risk management with primary care physicians. Patient Educ Couns. 2005;57(1):77–87.CrossRefPubMed

29.

National Kidney Disease Education P. Health professionals. http://nkdep.nih.gov/professionals/index.htm. Accessed July 17, 2009.

30.

Boulware LE. Challenges for public campaigns to improve the health of persons at high risk of developing CKD. Am J Kidney Dis. 2008;51(4):535–8.CrossRefPubMed

31.

Niederdeppe J, Levy AG. Fatalistic beliefs about cancer prevention and three prevention behaviors. Cancer Epidemiol Biomarkers Prev. 2007;16(5):998–1003.CrossRefPubMed

32.

Farmer D, Reddick B, D'Agostino R, Jackson SA. Psychosocial correlates of mammography screening in older African American women. Oncol Nurs Forum. 2007;34(1):117–23.CrossRefPubMed

33.

Russell KM, Perkins SM, Zollinger TW, Champion VL. Sociocultural context of mammography screening use. Oncol Nurs Forum. 2006;33(1):105–12.CrossRefPubMed

34.

Greiner KA, James AS, Born W, et al. Predictors of fecal occult blood test (FOBT) completion among low-income adults. Prev Med. 2005;41(2):676–84.CrossRefPubMed

35.

Burkhart PV, Rayens MK. Self-concept and health locus of control: factors related to children’s adherence to recommended asthma regimen. Pediatr Nurs. 2005;31(5):404–9.PubMed

36.

Cvengros JA, Christensen AJ, Lawton WJ. The role of perceived control and preference for control in adherence to a chronic medical regimen. Ann Behav Med. 2004;27(3):155–61.CrossRefPubMed

37.

O’Hea EL, Grothe KB, Bodenlos JS, Boudreaux ED, White MA, Brantley PJ. Predicting medical regimen adherence: the interactions of health locus of control beliefs. J Health Psychol. 2005;10(5):705–17.CrossRefPubMed

38.

Dunbar-Jacob JM, Schlenk EA, Burke LE, Matthews JT. Predictors of patient adherence: patient characteristics. In: Schumamer SA, Schron EB, Ockene JK, McBee WL, eds. The Handbook of Health Behavior Change. 2nd ed. New York: Springer Publishing Company; 1998: 491–511.

39.

Glanz K, Lewis FM, Rimer BK. Part Two: Models of Indivudial Health Behavior. Health Behavior and Health Education. Theory, Research and Practice. San Francisco: Jossey-Bass, Inc.; 1997.

40.

DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45(6):521–8.CrossRefPubMed

41.

Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.PubMed

42.

Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22(3):312–8.PubMed

43.

Officers A, Coordinators for the ACRG. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002;288(23):2998–3007.CrossRef

44.

Rahman M, Pressel S, Davis BR, et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165(8):936–46.CrossRefPubMed

Titel: Perceived Susceptibility to Chronic Kidney Disease among High-risk Patients Seen in Primary Care Practices
verfasst von: L. Ebony Boulware, MD, MPH
Kathryn A. Carson, ScM
Misty U. Troll, MPH
Neil R. Powe, MD, MPH, MBA
Lisa A. Cooper, MD, MPH
Publikationsdatum: 01.10.2009
Verlag: Springer-Verlag
Erschienen in: Journal of General Internal Medicine / Ausgabe 10/2009
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-009-1086-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Perceived Susceptibility to Chronic Kidney Disease among High-risk Patients Seen in Primary Care Practices